Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Elevance (ELV) PT Lowered to $515 at Leerink Partners
October 21, 2024 5:57 AM EDTLeerink Partners analyst Whit Mayo lowered the price target on Elevance (NYSE: ELV) to $515.00 (from $620.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: Reiterate Outperform Rating. 3Q results brought forth a material acceleration of pressures within Medicaid as a result of... More
Elevance (ELV) PT Lowered to $478 at RBC Capital
October 18, 2024 7:04 AM EDTRBC Capital analyst Ben Hendrix lowered the price target on Elevance (NYSE: ELV) to $478.00 (from $585.00) while maintaining a Outperform rating.
The analyst comments "ELV shares traded off today as management lowered its 2024 EPS guidance and guided to mid-single-digit EPS growth in 2025, down from... More



